Vote NO Pfizer offer, page-378

we are all well aware of how patents have an expiry date and when the patent expires a company that holds the patent is usually open to the potential of greater competition from other companies that would like to step in on its turf. I think ResApps patent for let's call it "cough sounds diagnosed through hand-held devices" expires in 2033 or thereabouts.
but, and this is a bloody big but... once the patent expires which company even then will be able to compete with us? None! Not only will our technology be embedded in telehealth platforms around the world, but no other competitor will be able to create a product anywhere equal to ours because they will not have a library of pre-covid cough sounds. no telehealth company is going to run an inferior second system in tandem with the First system.
We hold something unique beyond comparison.
How can anyone put a price on it?
We need to create a mindset amongst shareholders that values the company as invaluable. Think of ResApp with a market capitalisation in the billions in time, growing at a rate well above market average, with a price earnings ratio of between 40 and 60. Recalibrate your mind and think of a share price in the hundreds. Use cochlear as an example with its $250 share price. Then keep in mind Rap won't have anything like Cochlears annual expenses that run into hundreds of millions of dollars. Afterall, how much does it cost to run an app on the internet? Sweet nothing. Some of us bleet about Raps current annual expenditure but I think it is absolutely brilliant that it only costs 5 or 6 million a year to run our company and that's with all the r&d going on at present.
Our captain ie our board of directors like Ulysses are tied to the mast as we sail through perilous Waters towards our home. They appear to be insane, but it is only temporary. unlike Ulysses they were not able to warn us that they were going to behave temporarily insane. Non-disclosure clauses probably didn't exist in Homeric times. We must not cut them from the mast, or all will be lost.
I remember a story I used to read long ago. A child is walking home dressed in fine clothes. Tigers threaten to gobble him but the child convinces them to each settle for an item of his clothing instead. When the tigers see each other they are compelled to bite each other on the tail as none of them can afford to let the other be the grandest tiger in the jungle. They spin around the child who is safe up in a tree until they turn into butter. I don't know if this follows the laws of biomechanics, but I do think ResApp is going to butter its bread with the likes of pfizer and astrazeneca and Johnson and Johnson & co. They will become tangled in a gourdian knot and we will reap and proper if we don't sell out.
If a pfizer representative or whoever rings and asks for your valuation, tell them north of $250 per share to make them go away.
Hope I am just sounding off to those who are already converted. Don't tell my wife I referenced little black Sambo.